A healthy 46-year-old Japanese woman presented with a 6-day history of facial swelling and itching. She had taken a multi-ingredient cold medication including chlorpheniramine maleate 11 days previously. She developed a rash around both lower eyelids and applied an external solution 8 days previously. She also applied an external preparation of chlorpheniramine maleate 7 days previously. Physical examination revealed edematous erythema, papules, and erosive lesions on the patient's face, especially on the eyelids and cheeks (Fig. 1) . The lesions were localized to the sites to which the external preparation was applied. Epicutaneous patch tests revealed a positive reaction elevated pink or red plaques to 1% and 5% chlorpheniramine maleate 48 h later (Fig. 2, arrows) . Intracutaneous type IV allergy test was positive to chlorpheniramine maleate. A type IV delayed hypersensitivity reaction was diagnosed. Avoidance of the substances causing the reaction was recommended, and treatment with a medium potency topical corticosteroid was initiated. Symptoms had completely resolved at the 2-week followup (Fig. 3) . This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Discussion
The two main types of contact dermatitis are irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD) [1] . ICD is a localized inflammatory skin response to a wide range of chemical or physical agents; it results from the direct cytotoxic effect of irritants [1] . ACD is a delayed type IV hypersensitivity reaction to external chemicals that only occurs in susceptible individuals who have previously been sensitized [1] . Clinical features of contact dermatitis include erythema, edema, vesicles, bullae, and oozing [1] . The reaction is generally limited to the site of contact. Other clinical clues include the sparing of the area behind the ears, nasolabial folds, and under the chin. The flare-up observed around both lower eyelids in our case may also initially have been a drug-induced eruption (type IV allergy) in response to chlorpheniramine maleate, which was contained in the multi-ingredient cold medication; this was indicated by the symmetric appearance of symptoms and the course up to symptom onset. Patch testing may be required to confirm the diagnosis and to differentiate ACD from other types of eczematous dermatitis.
